Pharmacy Platform Directo Closes $2M Capital Raise to Enhance B2B Services

Monday, 9 September 2024, 21:48

Pharmacy platform Directo has successfully closed a capital raise of $2 million. This funding aims at expanding its reach in the growing pharmacy sector, capitalizing on their surging revenue to improve B2B marketplace offerings.
LivaRava_Medicine_Default.png
Pharmacy Platform Directo Closes $2M Capital Raise to Enhance B2B Services

Pharmacy Platform Directo Secures $2 Million

Pharmacy platform Directo has successfully closed a capital raise of $2 million to enhance its offerings in the pharmacy sector. This funding round is pivotal as Directo has experienced a surge in revenue, underscoring its potential in the B2B marketplace. The company plans to utilize these funds to expand its supplier and pharmacy base, fostering a more robust online platform for pharmacy professionals.

Impact on Pharmacy Sector

The influx of capital will allow Directo to enhance its services and reach within the pharmaceutical landscape. Continued investment in innovative technologies and suppliers can create pathways for improved business operations. As a result, businesses within this niche stand to benefit significantly from Directo's advancing capabilities.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe